Supplemental material
Emerging Microbes & Infections
Volume 13, 2024 - Issue 1
Open access
526
Views
0
CrossRef citations to date
0
Altmetric
Emerging and Re-Emerging Coronaviruses
Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control study
Siyue Jiaa NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, People’s Republic of ChinaView further author information
, Zundong Yinc China Center for Disease Control and Prevention, Beijing, People’s Republic of ChinaView further author information
, Hongxing Pana NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, People’s Republic of ChinaView further author information
, Fuzhen Wangc China Center for Disease Control and Prevention, Beijing, People’s Republic of ChinaView further author information
, Xiaoqiang Liud Yunnan Provincial Center for Disease Control and Prevention, Kunming, People’s Republic of ChinaView further author information
, Qing Wange Chongqing Provincial Center for Disease Control and Prevention, Chongqing, People’s Republic of ChinaView further author information
, Li Zhangf Shandong Provincial Center for Disease Control and Prevention, Jinan, People’s Republic of ChinaView further author information
, Jihai Tangg Anhui Provincial Center for Disease Control and Prevention, Hefei, People’s Republic of ChinaView further author information
, Hao Yangh Hunan Provincial Center for Disease Control and Prevention, Changsha, People’s Republic of ChinaView further author information
, Jiangbo Dub National Vaccine Innovation Platform and Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of ChinaView further author information
, Zhiguo Wanga NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, People’s Republic of ChinaView further author information
, Pengfei Jina NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, People’s Republic of ChinaView further author information
, Zhihang Pengb National Vaccine Innovation Platform and Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of ChinaView further author information
, Rong Tanga NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, People’s Republic of ChinaView further author information
, Guodong Kanga NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, People’s Republic of ChinaView further author information
, Xuewen Wangj Canming Medical Technology Co., Ltd, Shanghai, People’s Republic of ChinaView further author information
, Simin Lii School of Public Health, Southeast University; Nanjing, People’s Republic of ChinaView further author information
, Weixiao Wangb National Vaccine Innovation Platform and Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of ChinaView further author information
, Jingxin Lia NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, People’s Republic of China;b National Vaccine Innovation Platform and Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of China;i School of Public Health, Southeast University; Nanjing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
, View further author information
Hongbing Shenb National Vaccine Innovation Platform and Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of China;c China Center for Disease Control and Prevention, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
& View further author information
Fengcai Zhua NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, People’s Republic of China;b National Vaccine Innovation Platform and Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of China;i School of Public Health, Southeast University; Nanjing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
show allView further author information
Article: 2332660
|
Received 22 Dec 2023, Accepted 15 Mar 2024, Published online: 28 Apr 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.